fda tirzepatide osa The has expanded the approval of Eli Lilly's obesity medication Zepbound to include treating moderate to severe obstructive sleep apnea for people with obesity — the first medication approved for the Tirzepatide FDA approved for sleep

[7] [2] By 1986, the major review of the field by Graf and Kastin concluded that the various physiological functions of DSIP and its mechanism of action remain to be established. [2] That sentence was written four decades ago and has not been superseded

Performing the Aalens additive hazards model on the intention-to-treat analysis revealed a continuing downward slope for GLP-1 RAs and a less pronounced attenuation on intermediate time-scales (slope -0.0038, p = 0.015)

These benefits are particularly relevant for women who often present with atypical cardiovascular symptoms and higher heart failure risk

B-complex vitamins serve as coenzymes or precursors in numerous biochemical reactions, and together they work synergistically to support metabolism, neurological function, and cellular energy production

Despite this brief duration, GLP-1 exerts significant physiological effects on glucose homeostasis, appetite regulation, and gastric emptying

Knowing when to seek medical advice about your GLP-1 therapy is essential for optimising treatment outcomes and ensuring patient safety